SEN-1176

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSEN-1176
Drug Alias Nameneuroinflammation inhibitor (Senexis)BGC-0406SEN-1176
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 beta inhibitorsNitric oxide synthesis inhibitorsIL-6 receptor antagonists +[6] 
TargetsIL-6 receptorTumor necrosis factor αInterleukin-1 beta +[4] 
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSenexis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSenexis Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A